Savara Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Savara Inc (SVRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 90.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 65.00K shares, a 66.15% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 25.00K shares, a 74.36% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 100.00K shares, a 97.58% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 20.00K shares, a 90.48% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 409.50K shares, a 91.05% decline from fiscal 2024.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.57M shares, a 118.59% increase from fiscal 2023.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.09M shares, a 25.60% decline from fiscal 2022.
- Savara Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.81M shares, a 36.50% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 65.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 90.00K shares 10-Q · filed 2026-08-11 | 190.00K shares derived: sum of 3 quarters · filed 2026-08-11 | 210.00K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 25.00K shares 10-Q · filed 2026-05-12 | 125.00K shares derived: sum of 2 quarters · filed 2026-05-12 | 145.00K shares derived: sum of 3 quarters · filed 2026-05-12 | 337.00K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 120.00K shares derived: sum of 2 quarters · filed 2026-03-13 | 312.00K shares derived: sum of 3 quarters · filed 2026-03-13 | 409.50K shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 212.00K shares derived: sum of 2 quarters · filed 2025-11-12 | 309.50K shares 10-Q · filed 2025-11-12 | 4.44M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 192.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 289.50K shares 10-Q · filed 2025-08-13 | 4.42M shares derived: sum of 3 quarters · filed 2025-08-13 | 4.63M shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 97.50K shares 10-Q · filed 2025-05-13 | 4.23M shares derived: sum of 2 quarters · filed 2025-05-13 | 4.44M shares derived: sum of 3 quarters · filed 2025-05-13 | 4.48M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 4.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 4.34M shares derived: sum of 2 quarters · filed 2025-03-27 | 4.38M shares derived: sum of 3 quarters · filed 2025-03-27 | 4.57M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 210.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 245.00K shares derived: sum of 2 quarters · filed 2024-11-12 | 440.00K shares 10-Q · filed 2024-11-12 | 1.61M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 230.00K shares 10-Q · filed 2024-08-12 | 1.40M shares derived: sum of 3 quarters · filed 2024-08-12 | 1.55M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 195.00K shares 10-Q · filed 2024-05-09 | 1.37M shares derived: sum of 2 quarters · filed 2024-05-09 | 1.52M shares derived: sum of 3 quarters · filed 2024-05-09 | 1.71M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 1.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 1.32M shares derived: sum of 2 quarters · filed 2024-03-07 | 1.52M shares derived: sum of 3 quarters · filed 2024-03-07 | 2.09M shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 345.00K shares derived: sum of 2 quarters · filed 2023-11-09 | 920.00K shares 10-Q · filed 2023-11-09 | 3.45M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 195.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 770.00K shares 10-Q · filed 2023-08-10 | 3.30M shares derived: sum of 3 quarters · filed 2023-08-10 | 3.49M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 575.00K shares 10-Q · filed 2023-05-15 | 3.10M shares derived: sum of 2 quarters · filed 2023-05-15 | 3.29M shares derived: sum of 3 quarters · filed 2023-05-15 | 3.35M shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 2.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 2.72M shares derived: sum of 2 quarters · filed 2023-03-30 | 2.77M shares derived: sum of 3 quarters · filed 2023-03-30 | 2.81M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 190.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 245.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 285.00K shares 10-Q · filed 2022-11-10 | 1.68M shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 55.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 95.00K shares 10-Q · filed 2022-08-11 | 1.49M shares derived: sum of 3 quarters · filed 2022-08-11 | 1.91M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 40.00K shares 10-Q · filed 2022-05-11 | 1.43M shares derived: sum of 2 quarters · filed 2022-05-11 | 1.85M shares derived: sum of 3 quarters · filed 2022-05-11 | |
| 2021-12-31 | 1.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 1.81M shares derived: sum of 2 quarters · filed 2022-03-30 | 2.06M shares 10-K · filed 2022-03-30 | |
| 2021-09-30 | 425.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 670.00K shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 245.00K shares 10-Q · filed 2021-08-12 | |||
| 2020-09-30 | 901.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 933.64K shares 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 32.00K shares 10-Q · filed 2021-08-12 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-06 | 318.20K shares derived: sum of 3 quarters · filed 2017-03-06 | 8.15M shares 10-K · filed 2017-03-06 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 318.20K shares derived: sum of 2 quarters · filed 2016-11-08 | 8.15M shares 10-Q · filed 2016-11-08 | 8.72M shares derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | 318.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 8.15M shares 10-Q · filed 2016-08-09 | 8.72M shares derived: sum of 3 quarters · filed 2016-08-09 | 8.75M shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 7.83M shares 10-Q · filed 2016-05-06 | 8.40M shares derived: sum of 2 quarters · filed 2016-05-06 | 8.43M shares derived: sum of 3 quarters · filed 2016-05-06 | 12.36M shares derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | 566.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 596.67K shares derived: sum of 2 quarters · filed 2016-03-14 | 4.53M shares derived: sum of 3 quarters · filed 2016-03-14 | 13.11M shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 30.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 3.96M shares derived: sum of 2 quarters · filed 2015-11-12 | 12.55M shares 10-Q · filed 2015-11-12 | 13.15M shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 3.93M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 12.52M shares 10-Q · filed 2015-08-12 | 13.12M shares derived: sum of 3 quarters · filed 2015-08-12 | 13.12M shares derived: sum of 4 quarters · filed 2015-08-12 |
| 2015-03-31 | 8.59M shares 10-Q · filed 2015-05-11 | 9.19M shares derived: sum of 2 quarters · filed 2015-05-11 | 9.19M shares derived: sum of 3 quarters · filed 2015-05-11 | 13.88M shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 600.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | 600.00K shares derived: sum of 2 quarters · filed 2015-03-24 | 5.29M shares derived: sum of 3 quarters · filed 2015-03-24 | 7.48M shares 10-K · filed 2015-03-24 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 4.69M shares derived: sum of 2 quarters · filed 2014-10-31 | 6.88M shares 10-Q · filed 2014-10-31 | 7.06M shares derived: sum of 4 quarters · filed 2014-10-31 |
| 2014-06-30 | 4.69M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 6.88M shares 10-Q · filed 2014-08-11 | 7.06M shares derived: sum of 3 quarters · filed 2014-08-11 | |
| 2014-03-31 | 2.19M shares 10-Q · filed 2014-05-05 | 2.37M shares derived: sum of 2 quarters · filed 2014-05-05 | ||
| 2013-12-31 | 180.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | 3.95M shares 10-K · filed 2014-03-26 | ||
| 2013-09-30 | 3.77M shares 10-Q · filed 2013-11-04 | |||
| 2012-12-31 | 934.00K shares 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |